Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +8.47% | -3.03% | +122.61% |
04-22 | Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating | MT |
04-22 | Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating | MT |
Evolution of the average Target Price on Ocugen, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Ocugen, Inc.
Chardan Research | |
HC Wainwright | |
Cantor Fitzgerald | |
Mizuho Securities | |
Roth Capital Partners | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- OCGN Stock
- Consensus Ocugen, Inc.